Galmed Pharmaceuticals
GLMD
GLMD
31 hedge funds and large institutions have $24.5M invested in Galmed Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
28% less capital invested
Capital invested by funds: $34M → $24.5M (-$9.52M)
Holders
31
Holding in Top 10
1
Calls
$1K
Puts
–
Top Buyers
| 1 | +$2.98M | |
| 2 | +$1.47M | |
| 3 | +$192K | |
| 4 |
Squarepoint
New York
|
+$84.1K |
| 5 |
Goldman Sachs
New York
|
+$62K |
Top Sellers
| 1 | -$206K | |
| 2 | -$174K | |
| 3 | -$86K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$74K |
| 5 |
6CM
683 Capital Management
New York
|
-$62.9K |